United Therapeutics (UTHR) ROIC: History & Chart

Name: United Therapeutics Corporation (UTHR) Return on Invested Capital (ROIC) — historical time series
Creator: TGMCharts

Compare

United Therapeutics Corporation(UTHR)

Biotechnology · Silver Spring, MD

$497.11-6.75 (-1.34%)

Delayed quote: Sep 11, 2026, 4:00 PM EDT

Compare

About United Therapeutics Corporation

United Therapeutics Corporation, a biotechnology firm, is dedicated to discovering, developing, and bringing to market medical solutions for individuals suffering from chronic and severe, often life-threatening, illnesses. Its operations span both the United States and international markets. The company's current commercial portfolio features several key therapeutics: Remodulin, prescribed for pulmonary arterial hypertension (PAH) to lessen symptoms experienced during physical activity. Tyvaso, an inhaled form of the prostacyclin analogue treprostinil, designed to enhance exercise capacity in patients with PAH and pulmonary hypertension linked to interstitial lung disease (PH-ILD). Orenitram, a treprostinil tablet formulation, also aims to boost the exercise capabilities of PAH patients. Unituxin, a monoclonal antibody utilized in the treatment of high-risk neuroblastoma. Adcirca, an oral PDE-5 inhibitor, which helps improve exercise performance in those with PAH. United Therapeutics also maintains a robust development pipeline, including: Tyvaso DPI, a dry powder inhaler version of Tyvaso. The Remunity Pump, a compact, lightweight, and durable infusion system for treprostinil, accompanied by a separate controller. RemoPro and Ralinepag, both investigational treatments for PAH. Aurora-GT, a gene therapy product focused on regenerating blood vessels within the lungs. Clinical trials such as Tyvaso PERFECT and TETON, which are evaluating Tyvaso's efficacy in patients with World Health Organization (WHO) Group 3 pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD). The company has forged strategic alliances and licensing agreements with various entities, such as DEKA Research & Development Corp. for a semi-disposable subcutaneous treprostinil delivery system; MannKind Corporation for the development and licensing of treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. for the development of Ralinepag. Established in 1996, United Therapeutics Corporation is headquartered in Silver Spring, Maryland.

Silver Spring, MD

1,400 employees

www.unither.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Martine A. Rothblatt

View full financials

UTHR Return on Invested Capital (ROIC) Metrics

RETURN ON INVESTED CAPITAL (ROIC)

17.69%

RETURN ON INVESTED CAPITAL (ROIC) AVG TTM

16.84%

RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y

15.12%

RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y

14.88%

RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y

14.81%

RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y

15.95%

RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y

12.92%

CURRENT VS TTM AVG

+5.01%

CURRENT VS 3Y AVG

+16.97%

CURRENT VS 5Y AVG

+18.86%

CURRENT VS 10Y AVG

+19.42%

CURRENT VS 15Y AVG

+10.93%

CURRENT VS 20Y AVG

+36.94%

SECTOR MEDIAN · HEALTHCARE

8.75%

median of 90 covered companies

CURRENT VS SECTOR MEDIAN

+102.26%

vs the sector median at left

NAME	MARKET CAP	RETURN ON INVESTED CAPITAL (ROIC)	TTM	3Y	5Y
United Therapeutics Corporation (UTHR)	$21.10B	17.69%	16.84%	15.12%	14.88%
STERIS plc (STE)vs ›	$20.54B	8.74%	7.84%	7.14%	6.51%
Viatris Inc. (VTRS)vs ›	$19.23B	-0.29%	-4.13%	-1.14%	-0.84%
Zimmer Biomet Holdings, Inc. (ZBH)vs ›	$18.09B	5.51%	5.58%	5.01%	4.00%
BioNTech SE (BNTX)vs ›	$24.30B	-10.37%	-4.85%	9.52%	19.51%
West Pharmaceutical Services, Inc. (WST)vs ›	$24.37B	15.77%	14.65%	16.96%	17.76%
Incyte Corporation (INCY)vs ›	$24.62B	22.95%	10.25%	9.28%	7.08%
Labcorp Holdings Inc. (LH)vs ›	$25.55B	8.02%	6.33%	5.68%	7.63%
Medpace Holdings, Inc. (MEDP)vs ›	$16.40B	77.00%	52.59%	46.08%	35.95%
Quest Diagnostics Incorporated (DGX)vs ›	$25.94B	8.25%	7.70%	8.24%	10.04%

NAME

MARKET CAP

RETURN ON INVESTED CAPITAL (ROIC)

TTM

United Therapeutics Corporation (UTHR)

$21.10B

17.69%

16.84%

15.12%

14.88%

STERIS plc (STE)vs ›

$20.54B

8.74%

7.84%

7.14%

6.51%

Viatris Inc. (VTRS)vs ›

$19.23B

-0.29%

-4.13%

-1.14%

-0.84%

Zimmer Biomet Holdings, Inc. (ZBH)vs ›

$18.09B

5.51%

5.58%

5.01%

4.00%

BioNTech SE (BNTX)vs ›

$24.30B

-10.37%

-4.85%

9.52%

19.51%

West Pharmaceutical Services, Inc. (WST)vs ›

$24.37B

15.77%

14.65%

16.96%

17.76%

Incyte Corporation (INCY)vs ›

$24.62B

22.95%

10.25%

9.28%

7.08%

Labcorp Holdings Inc. (LH)vs ›

$25.55B

8.02%

6.33%

5.68%

7.63%

Medpace Holdings, Inc. (MEDP)vs ›

$16.40B

77.00%

52.59%

46.08%

35.95%

Quest Diagnostics Incorporated (DGX)vs ›

$25.94B

8.25%

7.70%

8.24%

10.04%

Return on Invested Capital (ROIC) Formula & Definition

ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)

Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.

Return on Invested Capital (ROIC) FAQ

What is the return on invested capital (ROIC) for United Therapeutics Corporation (UTHR)?

The return on invested capital (ROIC) for UTHR stock is 17.69%.

Is United Therapeutics Corporation's return on invested capital (ROIC) high or low?

The return on invested capital (ROIC) of 17.69% is 19% above its 5-year average of 14.88%, near the high end of its 5-year range (7.77%–18.81%).

What is the TTM average return on invested capital (ROIC) for United Therapeutics Corporation (UTHR)?

The TTM average return on invested capital (ROIC) for UTHR stock is 16.84%.

What is the 3Y average return on invested capital (ROIC) for United Therapeutics Corporation (UTHR)?

The 3Y average return on invested capital (ROIC) for UTHR stock is 15.12%.

What is the 5Y average return on invested capital (ROIC) for United Therapeutics Corporation (UTHR)?

The 5Y average return on invested capital (ROIC) for UTHR stock is 14.88%.

What is the 10Y average return on invested capital (ROIC) for United Therapeutics Corporation (UTHR)?

The 10Y average return on invested capital (ROIC) for UTHR stock is 14.81%.

What is the 15Y average return on invested capital (ROIC) for United Therapeutics Corporation (UTHR)?

The 15Y average return on invested capital (ROIC) for UTHR stock is 15.95%.

What is the 20Y average return on invested capital (ROIC) for United Therapeutics Corporation (UTHR)?

The 20Y average return on invested capital (ROIC) for UTHR stock is 12.92%.

DATE	RETURN ON INVESTED CAPITAL (ROIC)
2026-06-30	17.69%
2026-03-31	18.81%
2025-12-31	15.90%
2025-09-30	16.76%
2025-06-30	15.07%
2025-03-31	15.04%
2024-12-31	15.44%
2024-09-30	14.86%
2024-06-30	15.33%
2024-03-31	15.84%
2023-12-31	13.54%
2023-09-30	13.00%
2023-06-30	13.43%
2023-03-31	12.64%
2022-12-31	13.15%
2022-09-30	13.82%
2022-06-30	13.37%
2022-03-31	14.17%
2021-12-31	9.16%
2021-09-30	7.77%
2021-06-30	7.92%
2021-03-31	6.77%
2020-12-31	11.14%
2020-09-30	11.27%
2020-06-30	11.11%
2020-03-31	13.35%
2019-12-31	-5.07%
2019-09-30	-3.16%
2019-06-30	-4.16%
2019-03-31	-4.55%
2018-12-31	20.01%
2018-09-30	17.97%
2018-06-30	24.58%
2018-03-31	18.86%
2017-12-31	18.41%
2017-09-30	22.58%
2017-06-30	20.01%
2017-03-31	30.84%
2016-12-31	35.86%
2016-09-30	36.15%
2016-06-30	40.86%
2016-03-31	37.13%
2015-12-31	24.94%
2015-09-30	27.61%
2015-06-30	14.74%
2015-03-31	14.22%
2014-12-31	23.16%
2014-09-30	12.58%
2014-06-30	17.48%
2014-03-31	14.82%
2013-12-31	10.88%
2013-09-30	17.79%
2013-06-30	18.52%
2013-03-31	18.62%
2012-12-31	20.09%
2012-09-30	17.67%
2012-06-30	20.21%
2012-03-31	21.30%
2011-12-31	18.87%
2011-09-30	14.40%
2011-06-30	12.49%
2011-03-31	9.30%
2010-12-31	9.48%
2010-09-30	9.18%
2010-06-30	7.09%
2010-03-31	3.38%
2009-12-31	2.76%
2009-09-30	-15.02%
2009-06-30	-11.35%
2009-03-31	-9.04%
2008-12-31	-10.09%
2008-09-30	4.38%
2008-06-30	5.04%
2008-03-31	4.18%
2007-12-31	1.12%
2007-09-30	3.80%
2007-06-30	3.46%
2007-03-31	4.55%
2006-12-31	6.31%
2006-09-30	12.88%
2006-06-30	12.90%
2006-03-31	13.42%
2005-12-31	15.49%
2005-09-30	16.15%
2005-06-30	13.69%
2005-03-31	10.94%
2004-12-31	6.83%
2004-09-30	1.86%
2004-06-30	-2.37%
2004-03-31	-6.30%
2003-12-31	-6.79%
2003-09-30	-6.42%
2003-06-30	-9.18%

DATE

RETURN ON INVESTED CAPITAL (ROIC)

2026-06-30

17.69%

2026-03-31

18.81%

2025-12-31

15.90%

2025-09-30

16.76%

2025-06-30

15.07%

2025-03-31

15.04%

2024-12-31

15.44%

2024-09-30

14.86%

2024-06-30

15.33%

2024-03-31

15.84%

2023-12-31

13.54%

2023-09-30

13.00%

2023-06-30

13.43%

2023-03-31

12.64%

2022-12-31

13.15%

2022-09-30

13.82%

2022-06-30

13.37%

2022-03-31

14.17%

2021-12-31

9.16%

2021-09-30

7.77%

2021-06-30

7.92%

2021-03-31

6.77%

2020-12-31

11.14%

2020-09-30

11.27%

2020-06-30

11.11%

2020-03-31

13.35%

2019-12-31

-5.07%

2019-09-30

-3.16%

2019-06-30

-4.16%

2019-03-31

-4.55%

2018-12-31

20.01%

2018-09-30

17.97%

2018-06-30

24.58%

2018-03-31

18.86%

2017-12-31

18.41%

2017-09-30

22.58%

2017-06-30

20.01%

2017-03-31

30.84%

2016-12-31

35.86%

2016-09-30

36.15%

2016-06-30

40.86%

2016-03-31

37.13%

2015-12-31

24.94%

2015-09-30

27.61%

2015-06-30

14.74%

2015-03-31

14.22%

2014-12-31

23.16%

2014-09-30

12.58%

2014-06-30

17.48%

2014-03-31

14.82%

2013-12-31

10.88%

2013-09-30

17.79%

2013-06-30

18.52%

2013-03-31

18.62%

2012-12-31

20.09%

2012-09-30

17.67%

2012-06-30

20.21%

2012-03-31

21.30%

2011-12-31

18.87%

2011-09-30

14.40%

2011-06-30

12.49%

2011-03-31

9.30%

2010-12-31

9.48%

2010-09-30

9.18%

2010-06-30

7.09%

2010-03-31

3.38%

2009-12-31

2.76%

2009-09-30

-15.02%

2009-06-30

-11.35%

2009-03-31

-9.04%

2008-12-31

-10.09%

2008-09-30

4.38%

2008-06-30

5.04%

2008-03-31

4.18%

2007-12-31

1.12%

2007-09-30

3.80%

2007-06-30

3.46%

2007-03-31

4.55%

2006-12-31

6.31%

2006-09-30

12.88%

2006-06-30

12.90%

2006-03-31

13.42%

2005-12-31

15.49%

2005-09-30

16.15%

2005-06-30

13.69%

2005-03-31

10.94%

2004-12-31

6.83%

2004-09-30

1.86%

2004-06-30

-2.37%

2004-03-31

-6.30%

2003-12-31

-6.79%

2003-09-30

-6.42%

2003-06-30

-9.18%

Return on Invested Capital (ROIC): 17.69%

UTHR Return on Invested Capital (ROIC)

UTHR Average Return on Invested Capital (ROIC) Chart

UTHR Current vs Average Return on Invested Capital (ROIC) Chart

UTHR Return on Invested Capital (ROIC) Metrics

UTHR Competitors' Return on Invested Capital (ROIC)

Capital Efficiency

Return on Invested Capital (ROIC) Formula & Definition

Return on Invested Capital (ROIC) FAQ

UTHR Return on Invested Capital (ROIC) History

Related Metrics